Perrigo Company To Release Second Quarter Fiscal Year 2013 Results On Februa... ( ALLEGAN Mich. Jan. 18 2013 /...)

Perrigo Company To Release Second Quarter Fiscal Year 2013 Results On February 1, 2013

Date:1/18/2013

ALLEGAN, Mich., Jan. 18, 2013 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO;TASE:) today announced that it will release financial results for its second quarter fiscal year 2013 on Friday, February 1, 2013 at approximately 8:00 a.m. (ET). The Company will conduct a conference call at 10:00 a.m. (ET) hosted by Joseph C. Papa , Perrigo's Chairman, President and Chief Executive Officer.

(Logo: http://photos.prnewswire.com/prnh/20120301/DE62255LOGO)

The conference call will be available live via webcast to interested parties in the investor relations section of the Perrigo website at http://perrigo.investorroom.com/events-webcasts or by phone at 877-248-9413, International 973-582-2737, and reference ID# 87314407. A taped replay of the call will be available beginning at approximately 1:00 p.m. (ET) Friday, February 1, 2013 until midnight Friday, February 15, 2013. To listen to the replay, dial 855-859-2056, International 404-537-3406, and use access code 87314407.

From its beginnings as a packager of generic home remedies in 1887, Allegan, Michigan-based Perrigo Company has grown to become a leading global provider of quality, affordable healthcare products. Perrigo develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, dietary supplements and active pharmaceutical ingredients (API). The Company is the world's largest manufacturer of OTC pharmaceutical products for the store brand market. The Company's primary markets and locations of logistics operations have evolved over the years to include the United States, Israel, Mexico, the United Ki
'/>"/>

SOURCE Perrigo Company
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine technology :

1. Perrigo Company Will Release Third Quarter Fiscal 2012 Results On May 8, 2012
2. Perrigo Reports Record Third Quarter Revenue And Earnings And Raises Full Year EPS Guidance
3. Perrigo Company to Present at the Bank of America Merrill Lynch 2012 Healthcare Conference
4. Perrigo Announces FDA Final Approval and Launch of Store Brand OTC Lansoprazole 15mg Capsules
5. Perrigo Receives FDA Approval for Butoconazole Nitrate 2% Vaginal Cream
6. Perrigo Announces FDA Final Approval Of Tris Pharmas Dextromethorphan Polistirex Extended-Release Oral Suspension
7. Perrigo Company To Present At The William Blair Growth Stock Conference
8. Perrigo Receives FDA Approval And Commences Launch Of Clobetasol Propionate Shampoo, 0.05%
9. Perrigo Company Announces Quarterly Dividend
10. Perrigo Company To Present At The Morgan Stanley Global Healthcare Conference
11. Perrigo Company To Acquire Assets Of Sergeants Pet Care Products, Inc., For $285 Million

Post Your Comments:

(Date:5/22/2013)... 2013 Grifols, ein globales Unternehmen der ... , Spanien, präsentierte die Ergebnisse einer ... von PROLASTIN©-C (Alpha1-Proteinasehemmer [human]) den Spiegel des ... ein Niveau anhebt, das innerhalb des für ... ist eine lebensbedrohliche, genetische Erkrankung, bei der ...

(Date:5/22/2013)... Israel , May 22, 2013 /PRNewswire/ ... leading developer and provider of microRNA-based molecular diagnostics, announces ... and Chief Executive Officer of Rosetta Genomics, will deliver ... taking place from June 3-6, 2013 in New York ... June 4 th at 2:00 p.m. Eastern time. ...

(Date:5/22/2013)... , May 22, 2013 Medifocus, Inc. (OTCQX: MDFZF and ... , Chief Operating Officer, will present at the Second Annual ... New York City at the Grand ... to begin at 4:00 p.m. EDT and will be available ... http://wsw.com/webcast/marcum/mfs.v/ For more information and registration, ...

Breaking Medicine Technology:Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 2 Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 3 Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 4 Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference 2 Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference 3 Medifocus, Inc. to Present At The Second Annual Marcum LLP MicroCap Conference 2 Medifocus, Inc. to Present At The Second Annual Marcum LLP MicroCap Conference 3

[0] Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt [0] Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference [0] Medifocus, Inc. to Present At The Second Annual Marcum LLP MicroCap Conference

... June 21 Lexicon Pharmaceuticals, Inc. (Nasdaq: ... treatments for human disease, presented clinical data and analysis from ... patients with type 2 diabetes mellitus at ENDO 2010 today. ... of increased total GLP-1 in both LX4211 treatment arms relative ...

... 21 Reportlinker.com announces that a new market research report is available ... Global Coronary ... , , ... , , ...

Lexicon Presents Data Describing LX4211 Positive Phase 2 Clinical Results and Novel Mechanism of Action for Type 2 Diabetes Reportlinker Adds Global Coronary Stents Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

(Date:5/22/2013)... The Muscular Dystrophy Association scored a huge win in ... Muscle Team event held May 21 by raising more ... disease. , "The Charlotte community really showed up ... MDA Divisional Director Theresa Miller. “From the pro athletes ... make their night extra special, to the business and ...

(Date:5/22/2013)... Amy Norton HealthDay Reporter , , WEDNESDAY, May ... with athlete,s foot knows there is something about feet ... the first detailed "map" of the fungal groups that ... feet are the hottest neighborhood. It,s no secret ... such as bacteria, viruses and fungi, both outside and ...

(Date:5/22/2013)... People in the United States have been taking water ... much of the world, water shortages are normal and baths ... warns against taking water for granted and provides ways to ... in the United States. , Sharon Kleyne is host of ... live or by podcast on World Talk Radio, Voice America, ...

(Date:5/22/2013)... Bodybuilding.com is giving back to those who ... will be donating $1 from EVERY purchase made between 12:01am ... extremely grateful for the men and women who have served ... and founder of Bodybuilding.com. “It’s an honor to give back ... Heroes USA is an amazing organization that supports our nation’s ...

(Date:5/22/2013)... 22, 2013 Twenty student-led startup companies ... participating in an intensive startup accelerator designed to help ... services and create local jobs as part of ASU’s ... the Edson initiative offers approximately 20 student teams up ... and training to launch their for-profit, more-than-profit or nonprofit ...

[0] Charlotte Muscle Team Event Raises $300,000 in the Fight Against Muscle Disease [0] Scientists Map the Fungi on Your Feet [0] Water Advocate Sharon Kleyne Announces Water Conservation Appreciation [0] In the Spirit of Memorial Day, Bodybuilding.com is Donating a Portion of Their Sales to Hire Heroes [0] ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort

... health system of southern Australian hospitals has been graded at ... surgery admissions //and waiting times. ,This rating has ... recorded the second highest number of beds per capita in ... for every 1000 in population. ,Health Minister Tony ...

... New South Wales in Australia have developed a "super ... diabetes//, heart disease, arthritis and cancer. The drug, Dz13, ... aging as well, the researchers claimed. ,Also diseases like ... in a paper published in the latest issue of ...

... Pharma today said it has recieved a tentative New ... product used for treating HIV-1 infection//. ... drug product containing Lamivudine, Zidovudine, Nevirapine tablets used in ... Bombay Stock Exchange., ,The three drugs would now ...

... have discovered a method to cease the blood supply to ... cancer//. This, if proved conclusively, will infuse a new lease ... a protein, discovered while conducting a research on fruits, is ... them naturally. , ,The researchers said “By blocking the ...

... members and villagers, a woman who lost her husband to AIDS ... Bihar home. ,Premila Devi, 40, from Tilaei village in ... just a few months after her husband Sunil Mahto died of ... members as well as villagers treated her after her husband's death," ...

... determination test kits to counter online threats to its skewed ... Home DNA gender testing kit' for $275 promising results within ... unborn girls in Punjab, Haryana and Delhi. ,"We ... Health Minister Ramesh Chander Dogra told a news channel Sunday. ...

Cached Medicine News:Health News:South Australian health System In The Bottom Of Rankings 2

South Australian health System In The Bottom Of Rankings "Super Drug" Targets Disease-Causing Gene Aurobindo Gets Tentative USFDA Approval For Its HIV-1 Drug Cessation of blood supply to cancer cells may curtail spread, novel research Ostracized AIDS Patient Commits Suicide in Bihar Punjab Plans of Banning Sex Determination Kit from US

Tips are sharp on both sides to puncture, cut and tear the capsule...

... is designed to automatically measure and display ... with heart rate. It's a Blood Pressure ... ergometer and pharmacological stress test environments. Tango ... environments., ,Tango excels where other BP ...

...

... Tamp is an orthopedic balloon designed to ... Like an angioplasty balloon, it can be ... is inflated with radiopaque contrast medium. The ... volume. The force of balloon growth compacts ...

Medicine Products:

BD Visitec Irrigating Cystomes Tango Exercise Stress BP Monitor BD Visiwipe Instrument Wipes KyphX Xpander Inflatable Bone Tamp